Breast exam use during the protracted COVID-19 pandemic, by age, race, and geography

JNCI Cancer Spectr. 2023 Mar 1;7(2):pkad025. doi: 10.1093/jncics/pkad025.

Abstract

In this study we analyzed data collected from the onset of the COVID-19 pandemic through March 31, 2022, to identify temporal shifts in breast exam volume. Screening mammography volume stabilized toward the end of the study period, and diagnostic exam volume varied over time and by age. Older women experienced a decline in diagnostic exam volume between August 2020 and April 2021 that was not observed among women aged younger than 50 years (50-69 years: monthly percentage change [MPC] = -6.5%; and 70 years and older: MPC = -15.7%). With respect to breast biopsy volume, women aged younger than 70 years had increased exam volume beginning in April 2020 and June 2020, whereas a corresponding increase among older women was delayed until April 2021 (70 years and older: MPC = 9.3%). Findings from our study suggest a temporal shift in the use of breast exams that could result in differential detection of breast cancer by age.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / epidemiology
  • COVID-19* / epidemiology
  • Early Detection of Cancer
  • Female
  • Geography
  • Humans
  • Mammography
  • Pandemics